Oral contraceptive interaction inside Unfair is the medication-context label and interaction-screening surface that flags when a logged supplement may overlap pharmacologically with a user-reported oral contraceptive entry, framed as metadata for clinician review and not as contraception counseling.
What this label is
When a user reports an oral contraceptive in their medication list, Unfair stores it as a medication context entry. The label drives interaction screening across the stack so that compounds with known pharmacokinetic overlap can be surfaced inside the review. The label does not advise on which contraceptive to use, when to take it, or how to manage missed pills. Those decisions belong with a clinician.
How the screening surface works
A logged supplement is compared against the medication list during stack review. When an overlap is recognized, the surface raises an interaction risk note for the user to read. Common screening categories include hepatic enzyme pathway overlaps such as a CYP3A4 interaction and route-specific absorption context. The supplement stack mistakes guide frames why these overlaps deserve attention in a journal even when they do not feel symptomatic.
What the label is not
The label is not a guarantee of contraceptive efficacy with or without a supplement. It is not a place to log sexual health concerns. Users who want to evaluate efficacy or switch medications should read clinician guidance, not in-app copy.
User-reported, user-edited
Users add the contraceptive entry themselves and can edit or remove it. The interaction surface only updates when the user keeps the record current. Unfair does not infer this medication from other behavior.
Where this connects to other safety surfaces
The same record interacts with other safety surfaces. A new high-risk compound entry can route the user to a clinician consult prompt before the stack review continues. Users who want to test stack changes can use the journal to capture before and after symptoms for a clinician conversation.
How this appears in Unfair
The contraceptive entry appears in the medication list with a label. Stack review screens display interaction notes when overlaps are recognized.
Clinical safety note
This screening is not contraception counseling. Questions about contraceptive choice or efficacy after a stack change are a clinician consult conversation rather than an app workflow.